Daihan Pharmaceutical Launches 'Liposome Albumin King' with Enhanced Bioavailability
Combining 100% Albumin Complex with Liposome Formulation Technology
Daihan Pharmaceutical announced on March 12, 2026, that it has expanded its high-content albumin brand lineup 'Albumin King' by launching 'Liposome Albumin King,' which increases bioavailability in the body.
This product utilizes Daihan Pharmaceutical's proprietary technology, applying the 'liposome formulation technology,' in which nutrients are encapsulated by phospholipids similar to human cell membranes. Liposome formulation technology is effective in delivering nutrients stably into the body, thereby enhancing absorption compared to conventional formulations.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
The main ingredient of the product is a 100% albumin complex, which has undergone strict quality control. Each bottle of Liposome Albumin King contains 33,000 mg of high-content protein blend, designed to efficiently deliver nutrition. The product retains the liquid ampoule form, which had been highly preferred by existing consumers, to further enhance convenience of intake.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.